RecruitingACTRN12605000691640
The Role of Cognitive Behaviour Therapy in Cessation of Long Term Benzodiazepine Use and Outcome at 6 months
Sponsor
Queensland Health
Enrollment
100 participants
Start Date
Jul 1, 2004
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and females
Inclusion Criteria1
- a) have been receiving a daily dose of a benzodiazepine for a minimum continuous period of 3 months; and b) are on a stable maintenance dose of a benzodiazepine at the time of entry into the study (5-40 mg/day of diazepam or its equivalent).
Exclusion Criteria1
- a) have a current diagnosis of a psychotic disorder;b) are diagnosed with a gross brain disorder;c) have concurrent alcohol or other non-benzodiazepine drug dependence; d) are in current receipt of any other psychological treatment; or e) are pregnant or nursing.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Group 1 - Benzodiazepine dose reduction program initiated by General Practitioner plus immediate delivery of correspondence psychological skills program. Dose reduction is patient controlled and may t
Group 1 - Benzodiazepine dose reduction program initiated by General Practitioner plus immediate delivery of correspondence psychological skills program. Dose reduction is patient controlled and may take upto six months to cease use. Group 2 - Benzodiazepine dose reduction program initiated by General Practitioner plus 3 mths delayed delivery of correspondence psychological skills program. Dose reduction is patient controlled and may take upto six months to cease use.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000691640